Interserve addresses pension deficit
Support services and construction firm Interserve is to transfer its remaining interest in a portfolio of 19 PFI assets to the trustee of its pension scheme at a valuation of 55m pounds, the group announced on Wednesday.
Support services and construction firm Interserve is to transfer its remaining interest in a portfolio of 19 PFI assets to the trustee of its pension scheme at a valuation of 55m pounds, the group announced on Wednesday.
Interserve said that proposed transaction will provide a "significant contribution" towards its current pension scheme funding shortfall and will crystallise further value from its PFI investment portfolio.
The agreement is conditional upon the approval from shareholders at a meeting in January.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
In 2011, the interests contributed £3.7m of profit and gross assets were valued at £3.6m at June 30th 2012.
When combined with two previous transactions in relation to its PFI portfolio (announced in June and October), the deals will have raised £124.5m in cash to reduce the actuarial deficit from £150m to £95m and reduce the annual deficit recovery payment from £23.2m to £12m per annum.
"The transaction announced today is good news for both shareholders and members of our pension scheme," said Chief Executive Officer Adrian Ringrose.
"Through a series of transactions during 2012 we have realised significant latent value in our PFI portfolio and with today's announcement are proposing to bolster our pension position. The conclusion of our triennial pension funding review, of which this transaction is an integral part, balances the interests of our pension scheme with our ambition to make further progress against our strategic growth plans."
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published
-
Will the Autumn Budget impact investment markets?
Keir Starmer has warned the Autumn Budget will be “painful”. Will it impact investment markets and should you tweak your portfolio before 30 October?
By Katie Williams Published